Roderick De Greef's most recent trade in Biolife Solutions Inc was a trade of 11,101 Common Stock done at an average price of $19.1 . Disclosure was reported to the exchange on March 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.12 per share. | 19 Mar 2026 | 11,101 | 733,746 (3%) | 0% | 19.1 | 212,251 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.15 per share. | 11 Nov 2025 | 35,417 | 454,581 (2%) | 0% | 26.2 | 926,155 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.88 per share. | 11 Nov 2025 | 33,418 | 421,163 (2%) | 0% | 25.9 | 864,858 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.33 per share. | 11 Nov 2025 | 31,165 | 389,998 (1%) | 0% | 25.3 | 789,409 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.30 per share. | 22 Oct 2025 | 37,795 | 489,998 (2%) | 0% | 27.3 | 1,031,804 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 112,835 | 527,793 (2%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.43 per share. | 31 Oct 2024 | 46,896 | 414,958 (2%) | 0% | 23.4 | 1,098,773 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 29,206 | 469,103 (2%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.60 per share. | 08 Mar 2024 | 7,249 | 461,854 (2%) | 0% | 16.6 | 120,333 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.76 per share. | 19 Jan 2024 | 2,642 | 439,897 (2%) | 0% | 16.8 | 44,280 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 4,740 | 44,900 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 4,740 | 0 | - | - | Restricted Stock Award | |
| Biolife Soln Inc | Roderick De Greef | Director | Sale of securities on an exchange or to another person at price $ 23.19 per share. | 19 Jan 2023 | 3,801 | 40,160 (0%) | 0% | 23.2 | 88,145 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 9,647 | 43,961 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 20.59 per share. | 28 Nov 2022 | 33,905 | 34,314 (0%) | 0% | 20.6 | 698,104 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 21.44 per share. | 28 Nov 2022 | 5,400 | 69,719 (0%) | 0% | 21.4 | 115,776 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 20.75 per share. | 28 Nov 2022 | 4,600 | 75,119 (0%) | 0% | 20.8 | 95,450 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 28 Nov 2022 | 1,500 | 68,219 (0%) | 0% | 20.2 | 30,300 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 21.63 per share. | 21 Nov 2022 | 9,500 | 84,219 (0%) | 0% | 21.6 | 205,485 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 21 Nov 2022 | 4,500 | 79,719 (0%) | 0% | 21.7 | 97,695 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 23.57 per share. | 14 Nov 2022 | 14,000 | 102,719 (0%) | 0% | 23.6 | 329,980 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 24.53 per share. | 14 Nov 2022 | 6,000 | 96,719 (0%) | 0% | 24.5 | 147,180 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 22.69 per share. | 07 Oct 2022 | 8,552 | 116,719 (0%) | 0% | 22.7 | 194,045 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 21.95 per share. | 03 Oct 2022 | 1,233 | 125,271 (0%) | 0% | 21.9 | 27,064 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2022 | 535 | 126,504 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 683 | 125,969 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2022 | 828 | 125,286 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 15.79 per share. | 12 Jul 2022 | 9,158 | 124,458 (0%) | 0% | 15.8 | 144,605 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2022 | 900 | 133,616 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2022 | 955 | 132,716 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2022 | 957 | 131,761 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2022 | 1,024 | 130,804 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 17.59 per share. | 18 Apr 2022 | 18,530 | 129,780 (0%) | 0% | 17.6 | 325,943 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 43,846 | 0 | - | - | Restricted Stock Award | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 43,846 | 148,310 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 21.82 per share. | 07 Apr 2022 | 10,713 | 104,464 (0%) | 0% | 21.8 | 233,758 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 23,365 | 23,365 | - | - | Restricted Stock Award | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 23,365 | 115,177 (0%) | 0% | - | Common Stock | |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 30.75 per share. | 07 Jan 2022 | 8,196 | 94,432 (0%) | 0% | 30.8 | 252,027 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 30.75 per share. | 07 Jan 2022 | 2,053 | 92,379 (0%) | 0% | 30.8 | 63,130 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 30.75 per share. | 07 Jan 2022 | 567 | 91,812 (0%) | 0% | 30.7 | 17,435 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 39.37 per share. | 29 Dec 2021 | 705 | 102,628 (0%) | 0% | 39.4 | 27,756 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 51.08 per share. | 16 Nov 2021 | 7,000 | 110,333 (0%) | 0% | 51.1 | 357,560 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 50.75 per share. | 16 Nov 2021 | 7,000 | 103,333 (0%) | 0% | 50.8 | 355,250 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | COO & President | Sale of securities on an exchange or to another person at price $ 51.39 per share. | 16 Nov 2021 | 7,000 | 117,333 (0%) | 0% | 51.4 | 359,730 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.62 per share. | 25 Oct 2021 | 2,371 | 124,333 (0%) | 0% | 44.6 | 105,794 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 14 Oct 2021 | 1,221 | 126,704 (0%) | 0% | 40.0 | 48,803 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO | Sale of securities on an exchange or to another person at price $ 43.12 per share. | 28 Sep 2021 | 689 | 127,925 (0%) | 0% | 43.1 | 29,710 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO | Sale of securities on an exchange or to another person at price $ 44.75 per share. | 17 Aug 2021 | 12,000 | 150,853 (0%) | 0% | 44.8 | 537,000 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO | Sale of securities on an exchange or to another person at price $ 45.12 per share. | 17 Aug 2021 | 12,000 | 128,614 (0%) | 0% | 45.1 | 541,440 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO | Sale of securities on an exchange or to another person at price $ 44.81 per share. | 17 Aug 2021 | 12,000 | 162,853 (0%) | 0% | 44.8 | 537,720 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO | Sale of securities on an exchange or to another person at price $ 44.64 per share. | 17 Aug 2021 | 10,239 | 140,614 (0%) | 0% | 44.6 | 457,069 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO | Sale of securities on an exchange or to another person at price $ 43.75 per share. | 29 Jun 2021 | 685 | 174,853 (0%) | 0% | 43.8 | 29,969 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 5,959 | 0 | - | - | Stock Option (Right to Buy) | |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Sale of securities on an exchange or to another person at price $ 35.08 per share. | 13 Apr 2021 | 5,959 | 185,538 (0%) | 0% | 35.1 | 209,042 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 13 Apr 2021 | 5,959 | 191,497 (0%) | 0% | 1.6 | 9,773 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Sale of securities on an exchange or to another person at price $ 33.69 per share. | 13 Apr 2021 | 5,000 | 175,538 (0%) | 0% | 33.7 | 168,450 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Sale of securities on an exchange or to another person at price $ 33.83 per share. | 13 Apr 2021 | 5,000 | 180,538 (0%) | 0% | 33.8 | 169,150 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.81 per share. | 13 Apr 2021 | 4,000 | 189,538 (0%) | 0% | 1.8 | 7,240 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Sale of securities on an exchange or to another person at price $ 35.08 per share. | 13 Apr 2021 | 4,000 | 185,538 (0%) | 0% | 35.1 | 140,320 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 960 | 5,959 | - | - | Stock Option (Right to Buy) | |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Sale of securities on an exchange or to another person at price $ 35.08 per share. | 13 Apr 2021 | 960 | 185,538 (0%) | 0% | 35.1 | 33,677 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 13 Apr 2021 | 960 | 186,498 (0%) | 0% | 1.6 | 1,574 | Common Stock |
| Biolife Soln Inc | Roderick De Greef | CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 3,222 | 185,538 (0%) | 0% | - | Common Stock |